Finally, the observed association between impaired systemic and myocardial insulin sensitivity and myocardial dysfunction supports the notion that alterations in myocardial substrate supply and metabolism may affect the course of DCM. This evidence concerns the gene INS and familial dilated cardiomyopathy.